Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.
Revolution Medicines announced a stunning survival benefit for its experimental drug in a Phase 3 pancreatic cancer study ...
Discover how Anneo Biotech is quietly leading India's probiotic revolution, building the future of preventive healthcare.
In what looks to be the largest follow-on stock offering in biopharma history, US oncology company Revolution Medicines ...
ARLINGTON, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) announces that it is ready to ship its first commercial AI product in approximately 14 days, transforming the Company ...
CRISPR-Cas9 technology has revolutionized biotechnology by providing an efficient, precise, and versatile tool for genome editing. This RNA-guided system allows scientists to target specific DNA ...
Ahmedabad: While the state is often termed the ‘pharmacy of India' due to a mature ecosystem of pharmaceuticals in terms of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results